The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure.
暂无分享,去创建一个
[1] G. Filippatos,et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology , 2016, European journal of heart failure.
[2] N. Sattar,et al. Myocardial Hemorrhage After Acute Reperfused ST-Segment–Elevation Myocardial Infarction , 2016, Circulation. Cardiovascular imaging.
[3] E. Nagel,et al. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.
[4] M. Benson,et al. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis. , 2015, Journal of the American College of Cardiology.
[5] Jeroen J. Bax,et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. , 2015, The New England journal of medicine.
[6] M. Steinmetz,et al. Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics: Intervendor agreement and considerations regarding reproducibility , 2015, Clinical radiology.
[7] S. Pfaffenberger,et al. Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction , 2015, Journal of Cardiovascular Magnetic Resonance.
[8] J. Garot,et al. Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis , 2015, Journal of Cardiovascular Magnetic Resonance.
[9] P. Ponikowski,et al. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version. , 2015, European heart journal.
[10] B. Gerber,et al. Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study. , 2015, JACC. Cardiovascular imaging.
[11] G. Maurer,et al. Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance , 2015, PloS one.
[12] S. Iliceto,et al. Clinical presentation and diagnosis of myocarditis , 2015, Heart.
[13] B. Schnackenburg,et al. Performance of T1 and T2 Mapping Cardiovascular Magnetic Resonance to Detect Active Myocarditis in Patients With Recent-Onset Heart Failure , 2015, Circulation. Cardiovascular imaging.
[14] K. Klingel,et al. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy , 2015, Journal of Cardiovascular Magnetic Resonance.
[15] L. Vanhoutte,et al. Prospective cardiac MRI for the analysis of biventricular function in children undergoing cancer treatments , 2015, Pediatric blood & cancer.
[16] E. Nagel,et al. Myocardial Feature Tracking Reduces Observer-Dependence in Low-Dose Dobutamine Stress Cardiovascular Magnetic Resonance , 2015, PloS one.
[17] H. Katus,et al. Age- and gender-related normal left ventricular deformation assessed by cardiovascular magnetic resonance feature tracking , 2015, Journal of Cardiovascular Magnetic Resonance.
[18] M. Kuehl,et al. Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy. , 2015, JACC. Heart failure.
[19] Niloufar Zarinabad,et al. Feasibility of high-resolution quantitative perfusion analysis in patients with heart failure , 2015, Journal of Cardiovascular Magnetic Resonance.
[20] M. Garbi,et al. Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature review. , 2015, European heart journal cardiovascular Imaging.
[21] S. Piechnik,et al. T1 mapping and survival in systemic light-chain amyloidosis , 2014, European heart journal.
[22] E. Boerwinkle,et al. The amyloidogenic V122I transthyretin variant in elderly black Americans. , 2015, The New England journal of medicine.
[23] M. Mayr,et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. , 2015, JACC. Cardiovascular imaging.
[24] Richard B. Thompson,et al. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment , 2015, Heart Failure Reviews.
[25] S. Plein,et al. Non-invasive cardiac imaging evaluation of patients with chronic systolic heart failure: a report from the European Association of Cardiovascular Imaging (EACVI). , 2014, European heart journal.
[26] S. K. White,et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance , 2014, Journal of Cardiovascular Magnetic Resonance.
[27] Michael E. Hall,et al. Longitudinal Assessment of Concurrent Changes in Left Ventricular Ejection Fraction and Left Ventricular Myocardial Tissue Characteristics After Administration of Cardiotoxic Chemotherapies Using T1-Weighted and T2-Weighted Cardiovascular Magnetic Resonance , 2014, Circulation Cardiovascular Imaging.
[28] W. Tseng,et al. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. , 2014, JACC. Cardiovascular imaging.
[29] M. Cerqueira,et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2014, European heart journal cardiovascular Imaging.
[30] S. Nagueh. Anderson-Fabry Disease and Other Lysosomal Storage Disorders , 2014, Circulation.
[31] Daniel C. Lee,et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. , 2014, JACC. Cardiovascular imaging.
[32] M. Desai,et al. Infarct Characterization and Quantification by Delayed Enhancement Cardiac Magnetic Resonance Imaging Is a Powerful Independent and Incremental Predictor of Mortality in Patients With Advanced Ischemic Cardiomyopathy , 2014, Circulation. Cardiovascular imaging.
[33] J. Moon,et al. T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure , 2014, Current Cardiovascular Imaging Reports.
[34] D. Bluemke,et al. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update , 2014, Journal of Cardiovascular Magnetic Resonance.
[35] D. Bluemke,et al. Association of CMR-measured LA function with heart failure development: results from the MESA study. , 2014, JACC. Cardiovascular imaging.
[36] E. Nagel,et al. A selection of recent, original research papers , 2014, Journal of Nuclear Cardiology.
[37] M. Robson,et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.
[38] G. Aurigemma,et al. Systolic and Diastolic Mechanics in Stress Cardiomyopathy , 2014, Circulation.
[39] Jeroen J. Bax,et al. Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. , 2014, European heart journal.
[40] C. Catalano,et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. , 2014, JACC. Cardiovascular imaging.
[41] L. Anderson,et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. , 2014, JACC. Cardiovascular imaging.
[42] S. K. White,et al. Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.
[43] S. Plein,et al. Established and emerging cardiovascular magnetic resonance techniques for prognostication and guiding therapy in heart failure , 2014, Expert review of cardiovascular therapy.
[44] J. Zamorano,et al. The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. , 2014, European heart journal. Acute cardiovascular care.
[45] Katherine C. Wu,et al. Metabolic Rates of ATP Transfer Through Creatine Kinase (CK Flux) Predict Clinical Heart Failure Events and Death , 2013, Science Translational Medicine.
[46] G. Maurer,et al. Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2013, Circulation. Cardiovascular imaging.
[47] S. Flamm,et al. Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy: A Systematic Review , 2013, Circulation. Cardiovascular imaging.
[48] S. Raman,et al. Occult Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy , 2013, Circulation. Cardiovascular imaging.
[49] Sanjiv J. Shah. Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter. , 2013, Journal of the American College of Cardiology.
[50] Tevfik F Ismail,et al. The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy , 2013, Circulation.
[51] Stefan Neubauer,et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.
[52] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[53] M. Friedrich,et al. Cardiac Magnetic Resonance Assessment of Myocarditis , 2013, Circulation. Cardiovascular imaging.
[54] Richard B. Thompson,et al. T1 Mapping With Cardiovascular MRI Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Sex , 2013, Circulation. Cardiovascular imaging.
[55] R. Garg,et al. Heart Failure With a Normal Left Ventricular Ejection Fraction: Epidemiology, Pathophysiology, Diagnosis and Management , 2013, The American journal of the medical sciences.
[56] D. Pennell,et al. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. , 2013, Circulation.
[57] Richard B. Thompson,et al. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling , 2013, Journal of Cardiovascular Magnetic Resonance.
[58] E. Wellnhofer,et al. A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients. , 2013, Journal of the American College of Cardiology.
[59] D. Pennell,et al. Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non‐ischaemic dilated cardiomyopathy , 2013, European journal of heart failure.
[60] M. Cerqueira,et al. Identification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic Dysfunction: Inducible Ischemia Versus Hibernating Myocardium , 2013, Circulation. Cardiovascular imaging.
[61] T. Suter,et al. Cancer drugs and the heart: importance and management. , 2013, European heart journal.
[62] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[63] J. Schwitter,et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. , 2013, European heart journal.
[64] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[65] Edwin Wu,et al. Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. , 2013, JAMA.
[66] R. Kwong,et al. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. , 2013, The American journal of cardiology.
[67] E. Nagel,et al. European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries , 2013, Journal of Cardiovascular Magnetic Resonance.
[68] J. Kautzner,et al. Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy. , 2013, Journal of the American College of Cardiology.
[69] B. Gersh,et al. ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .
[70] S. Neubauer,et al. Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis , 2013, Heart Failure Reviews.
[71] A. Goldhirsch,et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[72] Andrew S Flett,et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease , 2012, Heart.
[73] A. Praestgaard,et al. Right Ventricular Structure Is Associated With the Risk of Heart Failure and Cardiovascular Death: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study , 2012, Circulation.
[74] E. Nagel,et al. Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. , 2012, Journal of the American College of Cardiology.
[75] S. Flamm,et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] Bernd Hamm,et al. Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard. , 2012, Journal of the American College of Cardiology.
[77] Mario J. Garcia,et al. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials. , 2012, JACC. Cardiovascular imaging.
[78] K. Klingel,et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.
[79] F. Pinto,et al. Looking for Myocardial Viability After a STICH Trial: Not Enough to Close the Door , 2012, The Journal of Nuclear Medicine.
[80] David Vancraeynest,et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. , 2012, Journal of the American College of Cardiology.
[81] S. Plein,et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.
[82] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[83] S. Petersen,et al. Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. , 2011, Progress in cardiovascular diseases.
[84] N. Osman,et al. Strain-encoded cardiac magnetic resonance during high-dose dobutamine stress testing for the estimation of cardiac outcomes. Comparison to clinical parameters and conventional wall motion readings , 2011, Journal of the American College of Cardiology.
[85] G. Schuler,et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.
[86] Pawan K. Singal,et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. , 2011, Journal of the American College of Cardiology.
[87] D. Berman,et al. Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.
[88] Dudley J Pennell,et al. On T2* Magnetic Resonance and Cardiac Iron , 2011, Circulation.
[89] Raymond J Kim,et al. The Role of Cardiac MR in New-Onset Heart Failure , 2011, Current cardiology reports.
[90] S. Neubauer,et al. Cardiovascular Magnetic Resonance in Heart Failure , 2011, Current cardiology reports.
[91] G. Schuler,et al. Prognostic value and determinants of a hypointense core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation myocardial infarction , 2011, Circulation. Cardiovascular imaging.
[92] E. Wellnhofer,et al. Long-term prognostic value of dobutamine stress CMR. , 2011, JACC. Cardiovascular imaging.
[93] Munir Pirmohamed,et al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology , 2011, European journal of heart failure.
[94] R. Carlson,et al. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? , 2010, Journal of the American College of Cardiology.
[95] G. Schuler,et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. , 2010, European heart journal.
[96] A. Tajik,et al. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. , 2010, JACC. Cardiovascular imaging.
[97] G. Schuler,et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. , 2010, Journal of the American College of Cardiology.
[98] N. Osman,et al. Strain-encoded CMR for the detection of inducible ischemia during intermediate stress. , 2010, JACC. Cardiovascular imaging.
[99] Matthew W. Martinez,et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. , 2010, JACC. Cardiovascular imaging.
[100] F. Veglia,et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. , 2010, Journal of the American College of Cardiology.
[101] S. Abbara,et al. Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major , 2010 .
[102] J. Estornell-Erill,et al. Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[103] J. Francis,et al. The role of cardiovascular magnetic resonance imaging in heart failure. , 2009, Journal of the American College of Cardiology.
[104] J. Min,et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. , 2009, JACC. Cardiovascular imaging.
[105] E. Yeh,et al. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. , 2009, Journal of the American College of Cardiology.
[106] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .
[107] EikeNagel,et al. Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes , 2009 .
[108] E. Nagel,et al. Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes , 2009, Circulation.
[109] M. Beer,et al. Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy Evidence for a Better Outcome With Early Treatment , 2009 .
[110] S. Neubauer,et al. Magnetic resonance spectroscopy in myocardial disease. , 2009, JACC. Cardiovascular imaging.
[111] Scott D Flamm,et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. , 2009, JACC. Cardiovascular imaging.
[112] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[113] A. van Rossum,et al. 123 Functional recovery after acute myocardial infarction: a comparison between angiography, electrocardiography and cardiovascular magnetic resonance measures of microvascular injury , 2008 .
[114] Matthew W. Darlison,et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[115] S. Neubauer,et al. Tako-tsubo cardiomyopathy presenting with features of left ventricular non-compaction. , 2008, International journal of cardiology.
[116] J. Carr,et al. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. , 2008, Journal of the American College of Cardiology.
[117] P. Algra,et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. , 2008, Journal of the American College of Cardiology.
[118] R. Kim,et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. , 2008, Journal of the American College of Cardiology.
[119] Katherine C. Wu,et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[120] Matthew W. Martinez,et al. Apical ballooning syndrome or aborted acute myocardial infarction? Insights from cardiovascular magnetic resonance imaging , 2008, The International Journal of Cardiovascular Imaging.
[121] John M Pauly,et al. Journal of Cardiovascular Magnetic Resonance Open Access Quantitative Characterization of Myocardial Infarction by Cardiovascular Magnetic Resonance Predicts Future Cardiovascular Events in Patients with Ischemic Cardiomyopathy , 2008 .
[122] K. Klingel,et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.
[123] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[124] S. Neubauer,et al. Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.
[125] André Lamy,et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). , 2007, Journal of the American College of Cardiology.
[126] Renu Virmani,et al. A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .
[127] R. Carlos,et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. , 2007, Journal of the American College of Cardiology.
[128] K. Dickstein,et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.
[129] M. Borggrefe,et al. Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy). , 2007, International journal of cardiology.
[130] D. Pennell,et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. , 2007, European heart journal.
[131] Katherine C. Wu,et al. Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.
[132] Stefan Neubauer,et al. The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.
[133] Giovanni Martinelli,et al. Prevention of High-Dose Chemotherapy-Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition , 2006, Circulation.
[134] Jaco J M Zwanenburg,et al. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. , 2006, Journal of the American College of Cardiology.
[135] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[136] Kevin C Oeffinger,et al. Chronic health conditions in adult survivors of childhood cancer. , 2006, The New England journal of medicine.
[137] K. Klingel,et al. Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.
[138] Peter C Austin,et al. Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.
[139] W. Stevenson,et al. Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.
[140] Richard D. White,et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. , 2006, American heart journal.
[141] G. Gensini,et al. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement. , 2006, American heart journal.
[142] M. Sheppard,et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[143] Robert G. Weiss,et al. Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.
[144] R. Kim,et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.
[145] J. Schulz-Menger,et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.
[146] F. Salvi,et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance , 2005, Heart.
[147] F. Ridocci,et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. , 2005, Journal of the American College of Cardiology.
[148] Paul A Bottomley,et al. ATP flux through creatine kinase in the normal, stressed, and failing human heart. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[149] R. Falk,et al. Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.
[150] Stefan Neubauer,et al. Value of Delayed-Enhancement Cardiovascular Magnetic Resonance Imaging in Predicting Myocardial Viability After Surgical Revascularization , 2004, Circulation.
[151] Jeroen J. Bax,et al. Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy. , 2004, The American journal of cardiology.
[152] Udo Sechtem,et al. Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.
[153] D. Pennell,et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.
[154] G. V. von Schulthess,et al. Characterization of Dysfunctional Myocardium by Positron Emission Tomography and Magnetic Resonance: Relation to Functional Outcome After Revascularization , 2003, Circulation.
[155] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[156] D. Pennell,et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.
[157] L. Shaw,et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.
[158] C. Hudis,et al. Cardiac dysfunction in the trastuzumab clinical trials experience. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[159] C. O'connor,et al. A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.
[160] D N Firmin,et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.
[161] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[162] G. Martinelli,et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. , 2000, Journal of the American College of Cardiology.
[163] D J Pennell,et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? , 2000, European heart journal.
[164] D J Pennell,et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[165] Katherine C. Wu,et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.
[166] S. Neubauer,et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. , 1997, Circulation.
[167] J H Patterson,et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. , 1996, Journal of the American College of Cardiology.
[168] B. Brent,et al. Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.
[169] J. Lowe,et al. The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.